Laboratoires (ALEMG) | Stock Overview & Key Data
Laboratoires Euromedis S.A. | Small-cap | Healthcare
Laboratoires Euromedis S.A. | Small-cap | Healthcare
Laboratoires Performance Comparison
Stock Range
Today's Range
Low: €4.23
High: €4.25
on August 22, 2025
52 Week Range
Low: €3.39
High: €5.44
on April 8, 2025
on August 23, 2024
All-Time High: €28.40 on February 24, 2020
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Market Cap
€12.1M
EPS
0.15
P/E Ratio (TTM)
28.20
Forward P/E
10.58
P/B Ratio
0.73
PEG Ratio
10.58
Div. Yield
N/A
ROE
-31.26%
Beta
0.276
Debt to Equity
48.76
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
5.27%
Profit Margin
-16.78%
Returns and Earnings
Return on Assets (TTM)
0.58%
Return on Equity (TTM)
-31.26%
EBITDA
€2.0M
Net Income (TTM)
€-6.1M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€12.76
Quarterly Revenue Growth (YoY)
93.50%
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Laboratoires ALEMG | 12.06M Small-cap | -1.40% | -3.20% | 3.68% | 0.71% | -3.64% | -19.89% | -28.91% | -53.77% |
| Bastide le Confort BLC | 207.60M Mid-cap | 2.71% | -7.34% | -2.74% | 8.40% | 20.85% | 30.88% | -23.24% | -36.47% |
| Metrics In Balance MLMIB | 790.30K Small-cap | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -90.00% | -98.99% |
| EssilorLuxottica EL | 126.95B Large-cap | 1.68% | 12.26% | 3.58% | -5.36% | 16.14% | 26.57% | 79.07% | 139.75% |
| Sartorius Stedim DIM | 17.57B Large-cap | 0.25% | 1.63% | -9.07% | -12.99% | -3.92% | 0.23% | -53.00% | -40.00% |
| bioMérieux S.A BIM | 15.02B Large-cap | 1.19% | 6.97% | 7.78% | 11.46% | 24.05% | 23.21% | 21.51% | 1.92% |
Ownership & Short Interest
Insider Ownership
64.33%
Institutional Ownership
1.67%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
172
Average 90-Day Volume
169
Laboratoires Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Laboratoires would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ALEMG's 52-week high and low?
- In the last 52 weeks, Laboratoires reached a high of €5.44 (on August 23, 2024) and a low of €3.39 (on April 8, 2025).
- What is the market cap and P/E ratio for ALEMG?
- Curious about Laboratoires's size and valuation? Its market capitalization stands at 12.06M. When it comes to valuation, the P/E ratio (trailing twelve months) is 28.20, and the forward P/E (looking ahead) is 10.58.
- Does ALEMG pay dividends? If so, what's the yield?
- As for dividends, Laboratoires isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Laboratoires's main competitors or similar companies to consider before investing?
When looking at Laboratoires, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Bastide le Confort
BLC207.60M Healthcare Medical Distribution 30.88% -23.24% Metrics In Balance
MLMIB790.30K Healthcare Medical Distribution 0.00% -90.00% EssilorLuxottica
EL126.95B Healthcare Medical Instruments & Supplies 26.57% 79.07% Sartorius Stedim
DIM17.57B Healthcare Medical Instruments & Supplies 0.23% -53.00% bioMérieux S.A
BIM15.02B Healthcare Diagnostics & Research 23.21% 21.51% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Laboratoires Euromedis S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Laboratoires's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -31.26%, the Debt to Equity ratio from the most recent quarter is 48.76, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for ALEMG?
- Looking at Laboratoires's growth, its revenue over the trailing twelve months (TTM) was €36M. Compared to the same quarter last year (YoY), quarterly revenue grew by 93.50%, and quarterly earnings saw a YoY growth of N/A.
- How much of ALEMG stock is held by insiders and institutions?
- Wondering who owns Laboratoires stock? Company insiders (like executives and directors) hold about 64.33% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 1.67%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.